Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (291-300 of 466) with videos related to

Pageof 47
Sort By:
Frontiers in Oncology|February 6, 2023
The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancerRyan M Finnegan, Ahmed M Elshazly, Nipa H Patel, et al.
Cancer Research|January 31, 2024
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic CancerVishnu Kumarasamy, Jianxin Wang, Costakis Frangou, et al.
Journal of Evaluation in Clinical Practice|October 8, 2021
A pilot study to evaluate feasibility and acceptability of training mental health workers in India to select case-specific intervention procedures within a dynamic modular treatment designed for a low-resource settingKendra S Knudsen, Kimberly D Becker, Karen Guan, et al.
Cancer Research|October 14, 2010
Alternative cyclin D1 splice forms differentially regulate the DNA damage responseZhiping Li, Xuanmao Jiao, Chenguang Wang, et al.
Biochimica Et Biophysica Acta|September 29, 2016
The Cohesive Metastasis Phenotype in Human Prostate CancerWilliam L Harryman, James P Hinton, Cynthia P Rubenstein, et al.
American Journal of Medical Genetics. Part A|June 15, 2007
Severe hypohidrotic ectodermal dysplasia in a girl caused by a de novo 9;X insertion that includes XIST and disrupts the EDA geneKaren Helene Ørstavik, Gun Peggy S Knudsen, Hilde Nordgarden, et al.
Oncotarget|July 10, 2015
Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancerAgnieszka K Witkiewicz, Nicholas A Borja, Jorge Franco, et al.
Cancer Research|July 10, 2007
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cellsAnkur Sharma, Clay E S Comstock, Erik S Knudsen, et al.
Molecular Cell|August 23, 2011
RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional controlRyan J Bourgo, Chellappagounder Thangavel, Adam Ertel, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancerWei Zhang, Qin Zhou, Jonathan V Nguyen, et al.
Pageof 47

Showing results (291-300 of 466) with videos related to

Sort By:
Pageof 47
Frontiers in Oncology|February 6, 2023
The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancerRyan M Finnegan, Ahmed M Elshazly, Nipa H Patel, et al.
Cancer Research|January 31, 2024
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic CancerVishnu Kumarasamy, Jianxin Wang, Costakis Frangou, et al.
Journal of Evaluation in Clinical Practice|October 8, 2021
A pilot study to evaluate feasibility and acceptability of training mental health workers in India to select case-specific intervention procedures within a dynamic modular treatment designed for a low-resource settingKendra S Knudsen, Kimberly D Becker, Karen Guan, et al.
Cancer Research|October 14, 2010
Alternative cyclin D1 splice forms differentially regulate the DNA damage responseZhiping Li, Xuanmao Jiao, Chenguang Wang, et al.
Biochimica Et Biophysica Acta|September 29, 2016
The Cohesive Metastasis Phenotype in Human Prostate CancerWilliam L Harryman, James P Hinton, Cynthia P Rubenstein, et al.
American Journal of Medical Genetics. Part A|June 15, 2007
Severe hypohidrotic ectodermal dysplasia in a girl caused by a de novo 9;X insertion that includes XIST and disrupts the EDA geneKaren Helene Ørstavik, Gun Peggy S Knudsen, Hilde Nordgarden, et al.
Oncotarget|July 10, 2015
Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancerAgnieszka K Witkiewicz, Nicholas A Borja, Jorge Franco, et al.
Cancer Research|July 10, 2007
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cellsAnkur Sharma, Clay E S Comstock, Erik S Knudsen, et al.
Molecular Cell|August 23, 2011
RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional controlRyan J Bourgo, Chellappagounder Thangavel, Adam Ertel, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Comparison of QuPath and HALO platforms for analysis of the tumor microenvironment in prostate cancerWei Zhang, Qin Zhou, Jonathan V Nguyen, et al.
Pageof 47